In Vitro Combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.

about

In Vitro Combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.

Item

http://www.wikidata.org/entity/Q48179374

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

In Vitro Combination of Isavuc ...... nd -Resistant Aspergillus spp.

@en

In Vitro Combination of Isavuc ...... nd -Resistant Aspergillus spp.

@nl

type

Item

label

In Vitro Combination of Isavuc ...... nd -Resistant Aspergillus spp.

@en

In Vitro Combination of Isavuc ...... nd -Resistant Aspergillus spp.

@nl

prefLabel

In Vitro Combination of Isavuc ...... nd -Resistant Aspergillus spp.

@en

In Vitro Combination of Isavuc ...... nd -Resistant Aspergillus spp.

@nl

P1476

In Vitro Combination of Isavuc ...... and -Resistant Aspergillus spp

@en

P2093

A Raffetin

http://www.w3.org/2001/XMLSchema#string

V Courbin

http://www.w3.org/2001/XMLSchema#string

V Jullien

http://www.w3.org/2001/XMLSchema#string

P2860

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillu

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.

The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.

In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp

Antifungal combination therapy: clinical potential.

P31

scholarly article

P356

10.1128/AAC.01382-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eric Dannaoui

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29038263

http://www.w3.org/2001/XMLSchema#string

P932

5740304

http://www.w3.org/2001/XMLSchema#string